Is Resgen overvalued or undervalued?

As of 18 November 2025, the valuation grade for Resgen has moved from fair to very attractive, indicating a significant improvement in its valuation outlook. The company is currently assessed as undervalued. Key ratios supporting this assessment include a PE ratio of 20.29, an EV to EBITDA ratio of 10.32, and a PEG ratio of 0.95, all of which suggest that Resgen is priced favorably compared to its earnings growth potential.
In comparison to its peers, Resgen's valuation metrics stand out. For instance, Larsen & Toubro has a much higher PE ratio of 34.3, and CG Power & Industries is deemed very expensive with a PE of 108.1. This places Resgen in a more attractive position relative to its industry, particularly given its solid ROCE of 20.21% and ROE of 12.95%. Despite recent stock performance lagging behind the Sensex, with a year-to-date decline of 33.99% compared to the Sensex's gain of 8.36%, the underlying valuation suggests that Resgen presents a compelling investment opportunity.